Recent News

• 04.22.2025 - Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain
• 03.10.2025 - Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)
• 02.25.2025 - Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando
• 02.05.2025 - 10-Q - Quarterly report pursuant to Section 13 or 15(d)

Recent Filings

• 04.07.2025 - EX-99.1 EX-99.1
• 04.07.2025 - 8-K Current report
• 03.25.2025 - 8-K Current report
• 02.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 01.30.2025 - 8-K Current report
• 01.03.2025 - 144/A Report of proposed sale of securities
• 01.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.03.2025 - 8-K Current report
• 01.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.03.2025 - 4 Statement of changes in beneficial ownership of securities